Therapeutic peptides can be designed to possess characteristics that provide both the target selectivity typically associated with parenterally delivered mAbs and an oral route of administration
Now picture a gentler path: slower weight change, protein-rich meals, an evening wind-down routine, and structured check-ins with a clinician
doi: 10.3389/fnut.2026.1794882 Received 23 January 2026 Revised 02 March 2026 Accepted 02 March 2026 Published 24 March 2026 Volume 13 - 2026 Edited by Amin Gasmi, Francophone Society of Nutritherapy and Applied Nutrigenetics, France Reviewed by Meryem Saban Gler, Batman University, Trkiye Updates Copyright 2026 Cengiz Kaynakc
There are no widespread, serious drug interactions reported at typical doses, but medical history matters
Post-surgical recovery timelines are often compressed compared to standard expectations